Interferon formation in chronic pyelonephritis patients
Shul'tsev, G.P.; Bektemirov, T.A.; Dibizheva, G.V.; Burtsev, V.I.
Klinicheskaia Meditsina 50(6): 62-65
1972
ISSN/ISBN: 0023-2149 PMID: 5086280 Document Number: 55121
Document emailed within 1 workday
Related Documents
Mauser-Bunschoten, E.P.; Damen, M.; Reesink, H.W.; Roosendaal, G.; Chamuleau, R.A.; van den Berg, H.M. 1996: Formation of antibodies to factor VIII in patients with hemophilia A who are treated with interferon for chronic hepatitis C Annals of Internal Medicine 125(4): 297-299Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Bocharov, A.F.; Lialina, M.I.; Moĭsiadi, S.A.; Shcheglovitova, O.N.; Bektemirov, T.A. 1972: Antibody- and interferon-formation in chronic relapsing aphthous stomatitis Voprosy Virusologii 17(1): 79-84
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130
Rudichenko, E.V.; Gvozdenko, T.A.; Antoniuk, M.V. 2006: Combined rehabilitation of patients with chronic pyelonephritis Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 3: 16-19
Kudriashova, I.P.; Ospel'nikova, T.P.; Smirnova, T.D.; Ershov, F.I. 2010: Interferons and other cytokines in patients with chronic pyelonephritis Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 9: 18-23
Gruev, I.; Kiperova, B.; Mavromatis, T.; Altŭnkova, I.; Bocheva, S. 1986: Immunoglobulins in the serum of chronic pyelonephritis patients Vutreshni Bolesti 25(1): 21-28
Kochemasova, Z.N.; Khamidova, G.K.; Kassirskaia, N.G.; Bakanova, D.I.; Marchenkova, V.A. 1975: Isolation of Mycoplasma from the urine of patients with chronic pyelonephritis Antibiotiki 20(11): 1035-1038
Pytel', I.A.; Zolotarev, I.I. 1983: Basic principles of treatment of patients with chronic pyelonephritis Terapevticheskii Arkhiv 55(6): 67-70
Lindh, J.; Anderson, U.; Britton, S.; De Ley, M. 1987: A single cell assay for the study of gamma-interferon formation in leprosy patients Clinical and Experimental Immunology 67(1): 51-54
Liul'ko, A.V.; Kropinov, P.I.; Slesarenko, E.G. 1977: Blood coagulation in patients with chronic pyelonephritis of the single kidney Vrachebnoe Delo 1977(1): 73-76
Androsova, S.O.; Nevraeva, O.G. 1978: Results of long-term observations in patients with chronic pyelonephritis Vrachebnoe Delo 4: 91-93
Schechter, H.; Leonard, C.D.; Scribner, B.H. 1971: Chronic pyelonephritis as a cause of renal failure in dialysis candidates. Analysis of 173 patients JAMA 216(3): 514-517
Ashimova, F.M. 1975: Interferon reaction of leukocytes in pyelonephritis in children Pediatriia 5: 77-78
Kobelev, A.A.; Lifanov, G.I.; Kosareva, P.I. 1982: Evaluation of the natural immunity of patients with chronic pyelonephritis (skin test with pyrogenal) Sovetskaia Meditsina 3: 100-101
Agadzhanian, I.G. 1975: Remote results of the treatment of patients with chronic pyelonephritis at the health resort Dzhermuk Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 6: 499-502
Shymonko, I.T. 2002: Enhancing efficiency of sanatorium treatment of patients with chronic pyelonephritis using hyperbaric oxygenation Likars'ka Sprava 8: 87-90
Todorova, V.; Sapundzhiev, K. 1989: Clinico-echographic parallels in patients with pyelonephritis and exacerbated chronic kidney failure Vutreshni Bolesti 28(5): 33-36
Guilhot, F. 1993: Interferon alfa and low-dose cytosine-arabinoside for the treatment of patients with chronic myelogenous leukemia in chronic phase. French CML Study Group Seminars in Hematology 30(3 Suppl 3: 24-25